SEC Form 4 · accession 0001382963-16-000234
JUNIPER PHARMACEUTICALS INC · JNP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
George Elston
Officer — Chief Financial Officer
Period of report
Aug 31, 2016
Accepted (ET)
Aug 31, 2016 · 5:10 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000821995
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| common stock, par value $0.01 | Aug 31, 2016 | P | 1,000 | $5.50 | A | 1,000 | D |
Table II — derivative securities
No Table II lines on this filing.